Identification |
Name: | (24E)-9-[2-(2,2-dimethyl-1-propylhydrazino)-2-oxoethoxy]-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate |
Synonyms: | Rifamycin B dimethylpropylhydrazide;NSC 144131;BRN 5418580;NCI 144-131;17607-49-7;Acetic acid, ((1,2-dihydro-5,6,17,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-9-yl)oxy)-,2,2-dimethyl-1-propylhydrazide, 21-acetate;Rifamycin, 4-O-(2-(2,2-dimethyl-1-propylhydrazino)-2-oxoethyl)-;Rifamycin, 4-O-[2-(2,2-dimethyl-1-propylhydrazino)-2-oxoethyl]-;LS-11773;Rifamycin B, 2,2-dimethyl-1-propylhydrazide;Rifamycin, 4-O-(2-(2,2-dimethyl-1-propylhydrazino)-2-oxoethyl)- (9CI) |
CAS: | 17607-49-7 |
Molecular Formula: | C44H61N3O13 |
Molecular Weight: | 839.9674 |
InChI: | InChI=1/C44H61N3O13/c1-13-18-47(46(10)11)32(49)21-57-31-20-29-39(53)34-33(31)35-41(27(7)38(34)52)60-44(9,42(35)54)58-19-17-30(56-12)24(4)40(59-28(8)48)26(6)37(51)25(5)36(50)22(2)15-14-16-23(3)43(55)45-29/h14-17,19-20,22,24-26,30,36-37,40,50-53H,13,18,21H2,1-12H3,(H,45,55)/b15-14+,19-17+,23-16u |
Molecular Structure: |
|
Properties |
Density: | 1.3g/cm3 |
Refractive index: | 1.611 |
Safety Data |
|
|